Jul 30, 2026 11:30PM
Jun 22, 2026 07:01AM
Jun 22, 2026 07:00AM
Jun 2, 2026 08:00AM
Apr 30, 2026 04:25AM
Jan 28, 2026 06:57AM
Jun 3, 2025 08:00AM AbbVie to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Apr 8, 2025 05:06AM
Feb 3, 2025 05:17AM
Jan 27, 2025 05:51AM
Jul 26, 2024 05:53AM
Jun 3, 2024 08:30AM
Feb 5, 2024 05:58AM
Dec 11, 2023 06:51AM Goldman Sachs Upgrades Abbvie (ABBV) to Buy amid execution on Humira and growth area
Nov 30, 2023 07:31AM
Nov 30, 2023 07:30AM
Jun 6, 2023 08:00AM
Feb 9, 2023 10:00AM
Oct 28, 2022 09:53AM
Feb 3, 2022 06:43AM
Dec 17, 2021 06:45AM UPDATE: Goldman Sachs Starts Abbvie (ABBV) at Neutral
Nov 19, 2021 09:53AM
Jun 2, 2021 08:30AM
Jun 3, 2020 08:00AM
Mar 10, 2020 05:39PM
Dec 31, 2019 09:11AM
Oct 22, 2019 05:54PM
Jun 7, 2019 08:00AM AbbVie to Present at the Goldman Sachs Global Healthcare Conference
May 28, 2019 02:37AM
Nov 1, 2018 07:11AM
Jun 14, 2018 12:39PM
Jun 5, 2018 08:21AM
May 29, 2018 08:00AM
May 24, 2018 05:05AM
May 2, 2018 06:01PM Goldman's Waldron says U.S. tax reform boosts shareholder activism
Apr 27, 2018 06:40AM
Apr 6, 2018 09:00AM
Mar 23, 2018 07:37AM
Dec 19, 2017 08:00AM
Dec 15, 2017 06:11AM
Nov 14, 2017 11:31AM
Nov 7, 2017 05:10AM AbbVie (ABBV) Remains The Most Attractive name In Biopharma - Goldman Sachs
Sep 8, 2017 04:17AM
Aug 14, 2017 05:43PM
May 24, 2017 08:00AM
May 15, 2017 03:23PM
Mar 10, 2017 05:46AM
Jan 4, 2017 06:40AM
Nov 9, 2016 12:03PM Complete Donald Trump Stock Impact Guide
Oct 31, 2016 10:37AM

188,556 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All